AUCKLAND, New Zealand--(BUSINESS WIRE)--Men with suspected prostate cancer are being urged to help Caldera Health perfect its urine diagnostic test.
Molecular diagnostic firm Caldera Health is in the final stages of developing a proprietary gene-sequencing test, but it needs more biopsy samples from men to further prove its concept.
Molecular diagnostic firm Caldera Health is in the final stages of developing a proprietary gene-sequencing test, but it needs more biopsy samples from men to further prove its concept.
